$0.281000
0.0310.63%
At Close: -
$0.301000
0.027.12%
After Hours: 7:59 PM EDT
15 minutes delayed
InMed Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of InMed Pharmaceuticals using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
INM | InMed Pharmaceuticals | -$0.19 | — | — | — | $1.24M | — | — | — | 09/11/2024 | Get Alert |
INM | InMed Pharmaceuticals | -$0.60 | — | -$0.18 | — | $1.03M | — | $1.17M | — | 05/14/2024 | Get Alert |
INM | InMed Pharmaceuticals | -$0.91 | — | -$0.19 | — | $469.78K | $1.39M | $1.24M | -10.79% | 02/13/2024 | Get Alert |
INM | InMed Pharmaceuticals | -$4.06 | — | -$0.76 | — | $320.79K | — | $901.86K | — | 11/14/2023 | Get Alert |
INM | InMed Pharmaceuticals | -$12.92 | — | $0.28 | — | $514.76K | — | $2.31M | — | 09/19/2023 | Get Alert |
INM | InMed Pharmaceuticals | -$6.25 | — | -$0.60 | — | $309.58K | — | $1.03M | — | 05/15/2023 | Get Alert |
INM | InMed Pharmaceuticals | -$7.75 | — | -$0.91 | — | $265.09K | — | $469.78K | — | 02/17/2023 | Get Alert |
INM | InMed Pharmaceuticals | -$6.25 | — | -$4.06 | — | $0.00 | — | $320.79K | — | 11/11/2022 | Get Alert |
INM | InMed Pharmaceuticals | -$10.25 | -$5.50 | -$12.92 | -134.91% | $0.00 | $750.00K | $514.76K | -31.37% | 09/23/2022 | Get Alert |
INM | InMed Pharmaceuticals | -$10.25 | — | -$6.25 | — | $0.00 | — | $309.58K | — | 05/13/2022 | Get Alert |
INM | InMed Pharmaceuticals | -$9.25 | -$5.75 | -$7.75 | -34.78% | $0.00 | $120.00K | $265.09K | 120.91% | 02/14/2022 | Get Alert |
INM | InMed Pharmaceuticals | -$7.75 | — | -$6.25 | — | $0.00 | — | $0.00 | — | 11/10/2021 | Get Alert |
INM | InMed Pharmaceuticals | — | — | -$10.25 | — | — | — | $0.00 | — | 09/24/2021 | Get Alert |
INM | InMed Pharmaceuticals | -$9.75 | — | -$10.25 | — | — | — | $0.00 | — | 05/13/2021 | Get Alert |
INM | InMed Pharmaceuticals | — | — | -$9.25 | — | — | — | $0.00 | — | 02/11/2021 | Get Alert |
INM | InMed Pharmaceuticals | -$16.25 | — | -$7.75 | — | $0.00 | — | $0.00 | — | 11/13/2020 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2022 | 2022-09-23 | $-12.92 | $-5.50 | -134.9 % |
Dec 2021 | 2022-02-14 | $-7.75 | $-5.75 | -34.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-02-13 | $1.24M | $1.39M | -10.8 % |
Jun 2022 | 2022-09-23 | $514.76K | $750.00K | -31.4 % |
Dec 2021 | 2022-02-14 | $265.09K | $120.00K | 120.9 % |
InMed Pharmaceuticals (INM) is scheduled to report earnings on September 11, 2024. The last reported earnings were for reported on May 14, 2024 for Q3.
The Actual EPS was $-0.18, which missed the estimate of $0.00.
The Actual Revenue was $1.2M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.